Clinical trials in the wake of Vioxx: requiring statistically extreme evidence of benefit to ensure the safety of new drugs
- PMID: 16684875
- DOI: 10.1161/CIRCULATIONAHA.105.604512
Clinical trials in the wake of Vioxx: requiring statistically extreme evidence of benefit to ensure the safety of new drugs
Comment in
-
Evaluating drug effects in the post-Vioxx world: there must be a better way.Circulation. 2006 May 9;113(18):2173-6. doi: 10.1161/CIRCULATIONAHA.106.625749. Circulation. 2006. PMID: 16684873 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
